Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. (300357.SZ)
CNY 19.91
(-0.75%)
CNY 19.91
(-0.75%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 848.19 Million CNY | -5.34% |
| 2022 | 896.01 Million CNY | 10.94% |
| 2021 | 807.69 Million CNY | 26.95% |
| 2020 | 636.2 Million CNY | -0.49% |
| 2019 | 639.35 Million CNY | 27.68% |
| 2018 | 500.74 Million CNY | 29.87% |
| 2017 | 385.57 Million CNY | 23.55% |
| 2016 | 312.08 Million CNY | 16.84% |
| 2015 | 267.1 Million CNY | 11.52% |
| 2014 | 239.51 Million CNY | 23.71% |
| 2013 | 193.6 Million CNY | 31.25% |
| 2012 | 147.51 Million CNY | 42.98% |
| 2011 | 103.17 Million CNY | 73.91% |
| 2010 | 59.32 Million CNY | 58.6% |
| 2009 | 37.4 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 210.79 Million CNY | -1.93% |
| 2024 Q3 | 300.98 Million CNY | 42.78% |
| 2024 Q1 | 214.95 Million CNY | 23.26% |
| 2023 Q4 | 174.39 Million CNY | -39.34% |
| 2023 FY | 848.19 Million CNY | -5.34% |
| 2023 Q1 | 183.13 Million CNY | -6.48% |
| 2023 Q2 | 203.15 Million CNY | 10.93% |
| 2023 Q3 | 287.49 Million CNY | 41.51% |
| 2022 FY | 896.01 Million CNY | 10.94% |
| 2022 Q4 | 195.83 Million CNY | -37.09% |
| 2022 Q1 | 197.58 Million CNY | 5.12% |
| 2022 Q2 | 191.31 Million CNY | -3.17% |
| 2022 Q3 | 311.27 Million CNY | 62.7% |
| 2021 Q3 | 272.11 Million CNY | 48.74% |
| 2021 FY | 807.69 Million CNY | 26.95% |
| 2021 Q1 | 164.65 Million CNY | 13.44% |
| 2021 Q2 | 182.95 Million CNY | 11.11% |
| 2021 Q4 | 187.97 Million CNY | -30.92% |
| 2020 Q1 | 110.27 Million CNY | -20.87% |
| 2020 FY | 636.2 Million CNY | -0.49% |
| 2020 Q4 | 145.14 Million CNY | -37.34% |
| 2020 Q3 | 231.63 Million CNY | 55.3% |
| 2020 Q2 | 149.15 Million CNY | 35.25% |
| 2019 FY | 639.35 Million CNY | 27.68% |
| 2019 Q4 | 139.35 Million CNY | -38.25% |
| 2019 Q3 | 225.66 Million CNY | 65.62% |
| 2019 Q2 | 136.25 Million CNY | -1.33% |
| 2019 Q1 | 138.08 Million CNY | 20.02% |
| 2018 Q1 | 106.93 Million CNY | 16.29% |
| 2018 Q4 | 115.05 Million CNY | -31.1% |
| 2018 FY | 500.74 Million CNY | 29.87% |
| 2018 Q3 | 166.98 Million CNY | 49.39% |
| 2018 Q2 | 111.77 Million CNY | 4.53% |
| 2017 Q1 | 81.09 Million CNY | 10.16% |
| 2017 Q2 | 84.03 Million CNY | 3.62% |
| 2017 Q3 | 128.48 Million CNY | 52.9% |
| 2017 Q4 | 91.95 Million CNY | -28.43% |
| 2017 FY | 385.57 Million CNY | 23.55% |
| 2016 FY | 312.08 Million CNY | 16.84% |
| 2016 Q1 | 69.11 Million CNY | 6.55% |
| 2016 Q2 | 64.29 Million CNY | -6.97% |
| 2016 Q3 | 105.05 Million CNY | 63.38% |
| 2016 Q4 | 73.61 Million CNY | -29.92% |
| 2015 FY | 267.1 Million CNY | 11.52% |
| 2015 Q4 | 64.86 Million CNY | -23.19% |
| 2015 Q3 | 84.45 Million CNY | 43.89% |
| 2015 Q2 | 58.69 Million CNY | -0.66% |
| 2015 Q1 | 59.08 Million CNY | 1.18% |
| 2014 Q1 | 51.91 Million CNY | 10.13% |
| 2014 Q4 | 58.39 Million CNY | -22.99% |
| 2014 Q3 | 75.82 Million CNY | 42.08% |
| 2014 Q2 | 53.36 Million CNY | 2.8% |
| 2014 FY | 239.51 Million CNY | 23.71% |
| 2013 Q1 | 43.05 Million CNY | 10.72% |
| 2013 FY | 193.6 Million CNY | 31.25% |
| 2013 Q4 | 47.14 Million CNY | -19.86% |
| 2013 Q3 | 58.81 Million CNY | 31.9% |
| 2013 Q2 | 44.59 Million CNY | 3.58% |
| 2012 FY | 147.51 Million CNY | 42.98% |
| 2012 Q4 | 38.88 Million CNY | -26.67% |
| 2012 Q3 | 53.03 Million CNY | 0.0% |
| 2011 FY | 103.17 Million CNY | 73.91% |
| 2010 FY | 59.32 Million CNY | 58.6% |
| 2009 FY | 37.4 Million CNY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Zhejiang Int'l Group Co.,Ltd. | 32.05 Billion CNY | 97.354% |
| Zhejiang Zhenyuan Share Co., Ltd. | 4.1 Billion CNY | 79.345% |
| Hunan Jingfeng Pharmaceutical Co.,Ltd. | 656.89 Million CNY | -29.121% |
| Hubei Guangji Pharmaceutical Co., Ltd. | 737.81 Million CNY | -14.959% |
| Yifan Pharmaceutical Co., Ltd. | 4.02 Billion CNY | 78.912% |
| Guangdong Jiaying Pharmaceutical Co., Ltd | 533.23 Million CNY | -59.066% |
| Sichuan Kelun Pharmaceutical Co., Ltd. | 21.15 Billion CNY | 95.99% |
| Chongqing Lummy Pharmaceutical Co., Ltd. | 895.59 Million CNY | 5.293% |
| Boai NKY Medical Holdings Ltd. | 1.58 Billion CNY | 46.433% |